Glenmark’s stunning Q1 performance: How the pharma powerhouse is dominating global markets

Pallavi Madhiraju- August 16, 2024 0

Glenmark Pharmaceuticals Limited (Glenmark) has announced impressive financial results for the first quarter of FY 2024-25, marked by a 6.9% increase in consolidated revenue and ... Read More

Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn

Pallavi Madhiraju- May 24, 2024 0

Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance ... Read More

Glenmark Pharmaceuticals to tap into $290m market with FDA approval for eye treatment solution

Pallavi Madhiraju- May 17, 2024 0

In a significant development for Glenmark Pharmaceuticals Ltd., the company has received final approval from the United States Food & Drug Administration (U.S. FDA) for ... Read More

Glenmark Pharmaceuticals secures FDA approval for generic version of Otezla Tablets

Pallavi Madhiraju- October 17, 2023 0

Glenmark Pharmaceuticals Ltd. has successfully secured the final approval from the United States Food & Drug Administration (U.S. FDA) for its Apremilast Tablets in 10 ... Read More

Ichnos Sciences strikes exclusive global deal with Astria Therapeutics for OX40 antibody portfolio

Pallavi Madhiraju- October 12, 2023 0

Ichnos Sciences, a prominent clinical-stage biotechnology firm specializing in pioneering multispecific antibodies for oncology and under the ownership of Glenmark Pharmaceuticals, has announced a momentous ... Read More

Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma Limited

Pallavi Madhiraju- September 21, 2023 0

Glenmark Pharmaceuticals (Glenmark Pharma), a research-led global pharmaceutical player, has inked a deal with Nirma Limited to divest a substantial 75% stake in its offshoot, ... Read More

Glenmark Pharmaceuticals gets FDA approval for generic Protopic Ointment

Pallavi Madhiraju- August 17, 2023 0

Glenmark Pharmaceuticals Ltd., a global leader in pharmaceutical research, has secured the final nod from the U.S. Food & Drug Administration (U.S. FDA) for its ... Read More

Glenmark Pharmaceuticals gets FDA final approval for Compazine generic

Pallavi Madhiraju- March 20, 2023 0

Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the US Food & Drug Administration (FDA). The ... Read More

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

Pallavi Madhiraju- March 17, 2023 0

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More

Glenmark Pharmaceuticals gets FDA second tentative approval for Saxagliptin Tablets

Pallavi Madhiraju- February 17, 2023 0

Glenmark Pharmaceuticals Inc., USA has secured a second tentative approval from the United States Food and Drug Administration (FDA) for Saxagliptin Tablets, 2.5 mg and ... Read More